Ortiz Vazquez Estephano Fabian, Londoño Victoria Juan Camilo, Castillo López Gabriela Alejandra, Hidalgo Tapia Esthela Carolina, Mena Acosta Francisco Isaac, Puchaicela Namcela Sisa Del Rocio
Obstetrics and Gynecology, Hospital Materno Infantil de Tijuana, Tijuana, MEX.
Obstetrics and Gynecology, Universidad de Antioquia, Medellín, COL.
Cureus. 2025 May 26;17(5):e84814. doi: 10.7759/cureus.84814. eCollection 2025 May.
Enhanced recovery after surgery (ERAS) protocols have significantly improved clinical outcomes in patients undergoing minimally invasive gynecological procedures. However, the absence of protocol uniformity among institutions, uneven implementation, uneven compliance, and the absence of research randomization limit the generalizability of findings. The aim of the review is to evaluate technological advancement, the efficacy of the integration of ERAS in minimally invasive gynecological surgery (MIGS) to improve clinical outcomes, challenges and controversies, and the way forward. The implementation of ERAS within minimally invasive gynecologic procedures leads to considerable positive results in postoperative outcomes. The implementation of ERAS protocols produces reduced pain and lower opioid requirements along with earlier patient mobilization and decreased hospital stays and an enhanced potential for same-day discharge for various benign and malignant gynecological procedures performed through laparoscopic, robotic, or vaginal techniques. The effectiveness of ERAS pathways demonstrates consistency among different surgical patient groups, such as adolescent and elderly women and gynecologic oncology patients, thus proving its broad clinical efficiency for current surgical procedures. A major benefit of this review stems from multiple research methods and extensive sample sizes, and multiple clinical settings to improve the universal application of research findings. The evidence showed that ERAS implementation was cost-effective, which proves it provides clinical and economic benefits. The implementation of ERAS protocols faces continued challenges because of diverse elements such as inconsistent patient adherence, possible publication bias, and insufficient long-term measurements. The studies use differing standardized outcome measures, which creates barriers to making direct outcome comparisons between them. The existing body of evidence supports establishing ERAS as a standard practice because it contributes to improved recovery and enhances both patient experience and healthcare operational effectiveness during minimally invasive gynecologic procedures.
术后加速康复(ERAS)方案显著改善了接受微创妇科手术患者的临床结局。然而,各机构之间方案缺乏一致性、实施不均衡、依从性参差不齐以及研究缺乏随机性,限制了研究结果的可推广性。本综述的目的是评估技术进步、ERAS整合到微创妇科手术(MIGS)中以改善临床结局的疗效、挑战与争议以及未来方向。在微创妇科手术中实施ERAS在术后结局方面产生了相当可观的积极结果。实施ERAS方案可减轻疼痛、减少阿片类药物用量,同时促进患者早期活动、缩短住院时间,并提高通过腹腔镜、机器人或阴道技术进行的各种良性和恶性妇科手术当日出院的可能性。ERAS路径的有效性在不同手术患者群体中表现出一致性,如青少年和老年女性以及妇科肿瘤患者,从而证明了其在当前手术中的广泛临床有效性。本综述的一个主要优势源于多种研究方法、大量样本量以及多种临床环境,以提高研究结果的普遍适用性。证据表明,实施ERAS具有成本效益,这证明它能带来临床和经济效益。由于患者依从性不一致、可能存在的发表偏倚以及长期测量不足等多种因素,ERAS方案的实施面临持续挑战。这些研究使用了不同的标准化结局测量方法,这为直接比较它们的结局造成了障碍。现有证据支持将ERAS确立为一种标准做法,因为它有助于改善康复,并在微创妇科手术期间提升患者体验和医疗运营效率。